ATAD1 and Plasmodium falciparum malaria: To our knowledge, this present study represents the first investigation of genetic diversity of Plasmodium falciparum populations to employ both msp-1 and msp-2 gene markers, 9 years after the implementation of ACTs for the treatment of uncomplicated Plasmodium falciparum malaria in Pointe-Noire.